Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

Carolyn F. Deacon, Jens Juul Holst

108 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab